1Kulchavenya E,Kim C S,Bulanova O,et al.Male genital tuberculosis:epidemiology and diagnostic[J].World journal of urology,2012,30(1):15-21.
2Mondal S K.Histopathologic analysis of female genital tuberculosis:a fifteen-year retrospective study of 110 cases in eastern India[J].Turk Patoloji Derg,2013,29(1):41-45.
3Oge T,Ozalp S S,Yalcin O T,et al.Peritoneal tuberculosis mimicking ovarian cancer[J].European Journal of Obstetrics&Gynecology and Reproductive Biology,2012,162(1):105-108.
5Thangappah R B P,Paramasivan C N,Narayanan S.Evaluating PCR,culture&histopathology in the diagnosis of female genital tuberculosis[J].The Indian journal of medical research,2011,134(1):40.
7Aboulfalah A,Fakhir B,Benkaddour Y A,et al.Clinical and anatomic features of female genital tuberculosis in 28 patients[J].International Journal of Gynecology&Obstetrics,2012,117(1):85-86.
8Ali A A A,Abdallah T M.Clinical presentation and epidemiology of female genital tuberculosis in eastern Sudan[J].International Journal of Gynecology&Obstetrics,2012,118(3):236-238.
3Demopoulos RI, Aronov R, Mesia A. Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohisto- chemical case control study[J].Int J Gynecol Pathol, 2001, 20 (2) :128-132.
4Lin HW, Tu YY, Lin SY, et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study[J]. Lancet Oncol, 2011, 12(9) :900-904.
6Riska A, Finne P, Alfthan H, et al. Past chlamydial infection is not associated with primary fallopian tube carcinoma [ J ]. Eur J Cancer, 2006, 42 (12) : 1835-1838.
7Riska A, Finne P, Koskela P, et al. Human papillomavirus in-fection and primary fallopian tube carcinoma : a seroepidemiologi- cal study[J]. BJOG, 2007, 114(4) :425-429.
8Gungor T, Keskin HL, Zergeroglu S, et al. Tuberculous salpin- gitis in two of five primary fallopian tube carcinomas[ J]. J Ob- stet Gynaecol, 2003, 23 ( 2 ) : 193-195.
9Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation [J]. JAMA, 2006, 296(2) :185-192.
10Rebbeck TR, Kauff ND, Domchek SM, et al. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-o- ophorectomy in BRCA1 or BRCA2 mutation carriers[ J]. J Natl Cancer Inst, 2009, 101 (2) :80-87.
